by KeyaMedical | Apr 13, 2021 | All News, Press
Keya Medical has received regulatory approval in China for its DeepVessel 3D Visualization Processing Software. The AI-based software medical device is designed for visualization reading of multiphase CT images and 3D models.
by KeyaMedical | Feb 25, 2021 | All News, Press
Keya Medical’s President of R&D, Dr. Kunlin Cao, has been recognized on the 2021 Forbes China Up-and-Coming Businesswomen list. The list highlights 20 accomplished women who have each played a significant role in shaping China’s business landscape.
by KeyaMedical | Jan 14, 2021 | All News, Investors, Press
Keya Medical has raised $46 million in Series D funding. This funding round was led by new and existing investors, including CICC Capital, Shanghai Artificial Intelligence Investment Fund, Qianhai Gaozu Asset Management Fund, and IN CAPITAL.
by KeyaMedical | Nov 12, 2020 | All News, Investors, Press
Keya Medical announced that it has completed a $30 Million Series C Funding Round led by IDG Capital, with participation from investors Alwin Capital, Source Code Capital, and Tasly Group.
by KeyaMedical | Oct 19, 2020 | Press
On Oct. 17 and 18, the Chengdu Science and Technology Bureau hosted the 2020 DEMO China Innovation Finals, bringing together leading companies across the country.
by KeyaMedical | Sep 18, 2020 | Press
On Sept. 18, Keya Medical was recognized as the winner of China’s Most Promising Company award because of its leading R&D team and innovative cardiovascular product line.
Recent Comments